These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 2030819)
1. Effects of intracerebroventricular administration of d-fenfluramine and d-norfenfluramine, as a single injection or 2-hr infusion, on serotonin in brain: relationship to concentrations of drugs in brain. Invernizzi R; Fracasso C; Caccia S; Garattini S; Samanin R Neuropharmacology; 1991 Feb; 30(2):119-23. PubMed ID: 2030819 [TBL] [Abstract][Full Text] [Related]
2. Impact of hypothalamic d-norfenfluramine and peripheral d-fenfluramine injection on macronutrient intake in the rat. Weiss GF; Rogacki N; Fueg A; Buchen D; Leibowitz SF Brain Res Bull; 1990 Dec; 25(6):849-59. PubMed ID: 2289171 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of repeated oral versus subcutaneous fenfluramine administration on rat brain monoamine neurons: pharmacokinetic and dose-response data. De Souza EB; Zaczek R; Culp S; Appel NM; Contrera JF Pharmacol Biochem Behav; 1991 Aug; 39(4):963-9. PubMed ID: 1763116 [TBL] [Abstract][Full Text] [Related]
4. The role of d-norfenfluramine in the indole-depleting effect of d-fenfluramine in the rat. Caccia S; Anelli M; Ferrarese A; Fracasso C; Garattini S Eur J Pharmacol; 1993 Mar; 233(1):71-7. PubMed ID: 7682511 [TBL] [Abstract][Full Text] [Related]
5. Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity and time course data. Zaczek R; Battaglia G; Culp S; Appel NM; Contrera JF; De Souza EB J Pharmacol Exp Ther; 1990 Apr; 253(1):104-12. PubMed ID: 2329498 [TBL] [Abstract][Full Text] [Related]
6. Fenfluramine and norfenfluramine levels in brain microdialysate, brain tissue and plasma of rats administered doses of d-fenfluramine known to deplete 5-hydroxytryptamine levels in brain. Clausing P; Newport GD; Bowyer JF J Pharmacol Exp Ther; 1998 Feb; 284(2):618-24. PubMed ID: 9454806 [TBL] [Abstract][Full Text] [Related]
8. Is receptor activation involved in the mechanism by which (+)-fenfluramine and (+)-norfenfluramine deplete 5-hydroxytryptamine in the rat brain? Invernizzi R; Kmieciak-Kolada K; Samanin R Br J Pharmacol; 1982 Mar; 75(3):525-30. PubMed ID: 6175368 [TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro interaction of flunarizine with D-fenfluramine serotonergic effects. Mennini T; Gobbi M; Crespi D; Cinquanta M; Frittoli E; Giorcelli P; Anelli M; Caccia S Pharmacol Biochem Behav; 1996 Jan; 53(1):155-61. PubMed ID: 8848445 [TBL] [Abstract][Full Text] [Related]
10. (+)-Fenfluramine and its major metabolite, (+)-norfenfluramine, are potent substrates for norepinephrine transporters. Rothman RB; Clark RD; Partilla JS; Baumann MH J Pharmacol Exp Ther; 2003 Jun; 305(3):1191-9. PubMed ID: 12649307 [TBL] [Abstract][Full Text] [Related]
11. The effect of D-fenfluramine on brain 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in male and female rats. Datla KP; Curzon G Eur J Pharmacol; 1997 Aug; 333(1):27-31. PubMed ID: 9311657 [TBL] [Abstract][Full Text] [Related]
12. Suppression of behavioral activity by norfenfluramine and related drugs in rats is not mediated by serotonin release. Callaway CW; Wing LL; Nichols DE; Geyer MA Psychopharmacology (Berl); 1993; 111(2):169-78. PubMed ID: 7870948 [TBL] [Abstract][Full Text] [Related]
13. The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux. Johnson GJ; Leis LA; Dunlop PC; Weir EK J Thromb Haemost; 2003 Dec; 1(12):2663-8. PubMed ID: 14675103 [TBL] [Abstract][Full Text] [Related]
14. Comparative serotonin neurotoxicity of the stereoisomers of fenfluramine and norfenfluramine. Johnson MP; Nichols DE Pharmacol Biochem Behav; 1990 May; 36(1):105-9. PubMed ID: 2140899 [TBL] [Abstract][Full Text] [Related]
15. Effect of escalating doses of d-fenfluramine on the content of indoles in brain. Caccia S; Sarati S; Anelli M; Garattini S Neuropharmacology; 1992 Sep; 31(9):875-9. PubMed ID: 1436395 [TBL] [Abstract][Full Text] [Related]
16. d-fenfluramine, but not d-norfenfluramine, uses calcium to increase extracellular serotonin. Puig de Parada M; Parada MA; Pothos E; Hoebel BG Life Sci; 1995; 56(22):PL415-20. PubMed ID: 7746089 [TBL] [Abstract][Full Text] [Related]
17. Differences between d-fenfluramine and d-norfenfluramine in serotonin presynaptic mechanisms. Borroni E; Ceci A; Garattini S; Mennini T J Neurochem; 1983 Mar; 40(3):891-3. PubMed ID: 6827286 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo effects of the anorectic agent dexfenfluramine on the central serotoninergic neuronal systems of non-human primates. A comparison with the rat. Mennini T; Fracasso C; Cagnotto A; Bergami A; Frittoli E; Gobbi M; Caccia S; Garattini S Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):641-7. PubMed ID: 8738297 [TBL] [Abstract][Full Text] [Related]
19. Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs. Mennini T; Bizzi A; Caccia S; Codegoni A; Fracasso C; Frittoli E; Guiso G; Padura IM; Taddei C; Uslenghi A Naunyn Schmiedebergs Arch Pharmacol; 1991 May; 343(5):483-90. PubMed ID: 1881458 [TBL] [Abstract][Full Text] [Related]
20. The effect of fenfluramine dosage regimen and reduced food intake on levels of 5-HT in rat brain. Rose S; Hindmarsh JG; Collins P; Jenner P J Neural Transm (Vienna); 1997; 104(11-12):1339-51. PubMed ID: 9503280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]